A licensed provider will develop a tailored treatment plan, inclusive of prescription weight loss medication, from oral to injectable options
However, not all patients feel comfortable using a syringe, so the development of oral medications or pills is seen as an important step in expanding access to treatment
My approach throughout this course will be consistent: I will start with the pathophysiology of a condition and then move on to how specific medications interrupt that pathophysiology
Similarly, patients on tirzepatide may encounter periods where weight loss seems to stall , and understanding the difference between a temporary plateau and true treatment failure helps prevent premature discontinuation
Hyperglycemia acutely lowers the postprandial excursions of glucagon-like peptide-1 and gastric inhibitory polypeptide in humans
Optimal results often build over 36 months or more